BLDR vs GGG

The company exhibits strong financial health with a Piotroski F-Score of 7/9, indicating solid operational and balance sheet fundamentals. However, despite this strength, the business is facing significant near-term headwinds, evidenced by sharp year-over-year declines in revenue (-6.9%) and earnings (-54.9%), which are weighing on performance. Valuation metrics suggest the stock is trading at a premium to both Graham’s defensive value ($67.26) and growth-based intrinsic value ($36.05), though below the sector’s elevated average P/E. Analysts maintain a 'buy' recommendation with a $131.00 target, implying upside potential if macro or operational conditions improve.

Graco Inc. (GGG) exhibits a stable financial health profile with a Piotroski F-Score of 4/9 and an exceptionally clean balance sheet (Debt/Equity 0.02). However, the stock is severely overvalued, trading at $80.54 despite a Graham Number of $33.74 and an Intrinsic Value of $21.42. Growth has stalled with negative YoY earnings growth (-2.80%) and a high PEG ratio of 2.52, indicating the price is not supported by current fundamentals. Bearish insider activity and a 0/100 technical trend further signal a lack of confidence in near-term upside.